Literature DB >> 18189051

Use of recombinant human thyroid-stimulating hormone for thyrotropin stimulation test in healthy, hypothyroid and euthyroid sick dogs.

Sylvie Daminet1, Lyanne Fifle, Manon Paradis, Luc Duchateau, Maxim Moreau.   

Abstract

Recombinant human thyroid-stimulating hormone (rhTSH) was evaluated for the diagnosis of canine hypothyroidism, using TSH response tests. Phase I stimulation tests were performed in 6 healthy dogs weighing over 20 kg, using 50 and then 100 microg of freshly reconstituted rhTSH administered intravenously. In phase II, the same dogs were stimulated by using 100 microg of rhTSH frozen for 3 months at -20 degrees C. Phase III stimulation tests were performed by using 50 or 100 microg of freshly reconstituted or frozen rhTSH in healthy (n = 14), euthyroid sick (n = 11) and hypothyroid dogs (n = 9). A dose of 100 microg of rhTSH was judged more appropriate for dogs weighing more than 20 kg. Biological activity of rhTSH after freezing at -20 degrees C for up to 12 weeks was maintained. When stimulated, significant (P < 0.05) increases in total thyroxine concentration were observed only in healthy and euthyroid sick dogs. Results of this study show that the rhTSH stimulation test is able to differentiate euthyroidism from hypothyroidism in dogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18189051      PMCID: PMC2081996     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  27 in total

1.  Serum thyroid hormone concentrations in clinically normal dogs after administration of freshly reconstituted vs previously frozen and stored thyrotropin.

Authors:  D L Kobayashi; R Nichols; M E Peterson
Journal:  J Am Vet Med Assoc       Date:  1990-09-01       Impact factor: 1.936

2.  Comparison of two doses of aqueous bovine thyrotropin for thyroid function testing in dogs.

Authors:  K M Beale; L J Helm; K Keisling
Journal:  J Am Vet Med Assoc       Date:  1990-10-01       Impact factor: 1.936

3.  The use of recombinant human thyrotropin produced by Chinese hamster ovary cells for the preparation of immunoassay reagents.

Authors:  M T Ribela; A C Bianco; P Bartolini
Journal:  J Clin Endocrinol Metab       Date:  1996-01       Impact factor: 5.958

Review 4.  Diagnosis of canine hypothyroidism. Perspectives from a testing laboratory.

Authors:  R J Kemppainen; E N Behrend
Journal:  Vet Clin North Am Small Anim Pract       Date:  2001-09       Impact factor: 2.093

5.  Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey.

Authors:  L E Braverman; B M Pratt; S Ebner; C Longcope
Journal:  J Clin Endocrinol Metab       Date:  1992-05       Impact factor: 5.958

Review 6.  Influence of drugs on thyroid function in dogs.

Authors:  Sylvie Daminet; Duncan C Ferguson
Journal:  J Vet Intern Med       Date:  2003 Jul-Aug       Impact factor: 3.333

7.  Evaluation of thyroid function in obese dogs and in dogs undergoing a weight loss protocol.

Authors:  S Daminet; I Jeusette; L Duchateau; M Diez; I Van de Maele; A De Rick
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2003-05

8.  Diagnostic use of recombinant human thyrotropin in patients with thyroid carcinoma (phase I/II study).

Authors:  C A Meier; L E Braverman; S A Ebner; I Veronikis; G H Daniels; D S Ross; D J Deraska; T F Davies; M Valentine; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

9.  Effect of thyrotropin storage on thyroid-stimulating hormone response testing in normal dogs.

Authors:  D S Bruyette; R W Nelson; G D Bottoms
Journal:  J Vet Intern Med       Date:  1987 Apr-Jun       Impact factor: 3.333

10.  Effects of administration of a low dose of frozen thyrotropin on serum total thyroxine concentrations in clinically normal dogs.

Authors:  M Paradis; E Laperrière; N Larivière
Journal:  Can Vet J       Date:  1994-06       Impact factor: 1.008

View more
  7 in total

1.  Inability of recombinant human thyrotropin to predict the evolution from subclinical hypothyroidism to overt disease. A pilot study.

Authors:  C Zafon; B Rodríguez; J B Montoro; D Cabo; J Mesa
Journal:  J Endocrinol Invest       Date:  2011-04-26       Impact factor: 4.256

2.  Human TSH receptor ligands as pharmacological probes with potential clinical application.

Authors:  Susanne Neumann; Bruce M Raaka; Marvin C Gershengorn
Journal:  Expert Rev Endocrinol Metab       Date:  2009-11-01

3.  Behavior in dogs with spontaneous hypothyroidism during treatment with levothyroxine.

Authors:  Alenka Hrovat; Tiny De Keuster; Hans S Kooistra; Luc Duchateau; Mark A Oyama; Kathelijne Peremans; Sylvie Daminet
Journal:  J Vet Intern Med       Date:  2018-11-30       Impact factor: 3.333

4.  Case Report: Technetium-99m Pertechnetate Scintigraphy Findings in a Dog With Iodine Deficiency-Induced Goitrous Hypothyroidism.

Authors:  Taesik Yun; Yejin Na; Dohee Lee; Yoonhoi Koo; Yeon Chae; Hyeyeon Nam; Byeong-Teck Kang; Mhan-Pyo Yang; Hakhyun Kim
Journal:  Front Vet Sci       Date:  2022-06-13

5.  Effect of recombinant human thyrotropin on the uptake of radioactive iodine (¹²³I) in dogs with thyroid tumors.

Authors:  Miguel Campos; Kathelijne Peremans; Eva Vandermeulen; Luc Duchateau; Tim Bosmans; Ingeborgh Polis; Sylvie Daminet
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

6.  Characterization of recombinant human and bovine thyroid-stimulating hormone preparations by mass spectrometry and determination of their endotoxin content.

Authors:  Sandra Schaefer; Paul O Hassa; Nadja S Sieber-Ruckstuhl; Marion Piechotta; Claudia E Reusch; Bernd Roschitzki; Felicitas S Boretti
Journal:  BMC Vet Res       Date:  2013-07-16       Impact factor: 2.741

7.  Pharmacokinetics of total thyroxine after repeated oral administration of levothyroxine solution and its clinical efficacy in hypothyroid dogs.

Authors:  I C van Dijl; G Le Traon; B D A M van de Meulengraaf; S Burgaud; L J I Horspool; H S Kooistra
Journal:  J Vet Intern Med       Date:  2014-04-28       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.